Case Report: Severe Peripartum Cardiac Disease in Myotonic Dystrophy Type 1

Background Myotonic dystrophy type 1 (DM1) is a hereditary muscular dystrophy affecting ∼2.1–14.3/100,000 adults. Cardiac manifestations of DM1 include conduction disorders and rarely cardiomyopathies. DM1 increases the risk of obstetric complications, however, little is known about the relationship between pregnancy and cardiomyopathy in DM1 due to disease rarity. Case A 23-year-old with DM1 developed cardiomyopathy during pregnancy. Despite initial medical stabilization, she subsequently developed multiple spontaneous coronary artery dissections postpartum, worsening cardiomyopathy and multiorgan failure. She died 5 months postpartum. Conclusion Though cardiomyopathy and arterial dissection are both known complications of pregnancy, this case suggests individuals with myotonic dystrophy type 1 may be at heightened risk for cardiac disease during the peripartum period. Physicians caring for women with suspected or proven DM1 should offer counseling and be alerted to the risk of cardiac complications with pregnancy and in the peripartum period. Pregnant and peripartum women with DM1 are likely to benefit from more frequent assessments of cardiac function including echocardiograms and early institution of heart failure management protocols when symptoms of cardiomyopathy present.

[1]  P. Ponikowski,et al.  Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy , 2019, European journal of heart failure.

[2]  J. Saw,et al.  Spontaneous coronary artery dissection: a review of complications and management strategies , 2019, Expert review of cardiovascular therapy.

[3]  M. Honigberg,et al.  Peripartum cardiomyopathy , 2019, British Medical Journal.

[4]  Jin-Sung Park,et al.  Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1 , 2018, Neurological Sciences.

[5]  J. Saw,et al.  Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association. , 2018, Circulation.

[6]  D. Hilfiker-Kleiner,et al.  Pregnancy and Heart Disease: Pregnancy-Associated Hypertension and Peripartum Cardiomyopathy. , 2017, Current problems in cardiology.

[7]  Paul J. Wang,et al.  Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association. , 2017, Circulation.

[8]  A. Lazarus,et al.  Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry , 2017, Circulation. Cardiovascular genetics.

[9]  G. Tomaselli,et al.  Left Ventricular Dysfunction and Conduction Disturbances in Patients With Myotonic Muscular Dystrophy Type I and II , 2017, JAMA cardiology.

[10]  J. Saw,et al.  Contemporary Review on Spontaneous Coronary Artery Dissection. , 2016, Journal of the American College of Cardiology.

[11]  C. Richards,et al.  Results from an external proficiency testing program: 11 years of molecular genetics testing for myotonic dystrophy type 1 , 2016, Genetics in Medicine.

[12]  C. Heatwole,et al.  The Impact of Pregnancy on Myotonic Dystrophy: A Registry-Based Study , 2015, Journal of neuromuscular diseases.

[13]  V. Feigin,et al.  Prevalence of Muscular Dystrophies: A Systematic Literature Review , 2014, Neuroepidemiology.

[14]  L. Køber,et al.  High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study. , 2014, International journal of cardiology.

[15]  J. Saw,et al.  Spontaneous coronary artery dissection: prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort. , 2013, JACC. Cardiovascular interventions.

[16]  L. Køber,et al.  Cardiac manifestations of myotonic dystrophy type 1. , 2012, International journal of cardiology.

[17]  K. Zerres,et al.  Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients. , 2012, European journal of obstetrics, gynecology, and reproductive biology.

[18]  Changyu Shen,et al.  Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. , 2010, American heart journal.

[19]  Y. Pinto,et al.  Hereditary muscular dystrophies and the heart , 2010, Neuromuscular Disorders.

[20]  K. Sliwa,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy , 2010, European journal of heart failure.

[21]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[22]  A. Sovari,et al.  Cardiovascular Manifestations of Myotonic Dystrophy-1 , 2007, Cardiology in review.

[23]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[24]  Santiago Reyes,et al.  Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. , 2004, Human molecular genetics.

[25]  K. Zerres,et al.  Outcome in pregnancies complicated by myotonic dystrophy: a study of 31 patients and review of the literature. , 2004, European journal of obstetrics, gynecology, and reproductive biology.

[26]  Teresa Foo,et al.  : SYSTEMATIC LITERATURE REVIEW , 2004 .

[27]  P. Merlet,et al.  Blunted coronary reserve in myotonic dystrophy. An early and gene-related phenomenon. , 1996, Circulation.

[28]  David E. Housman,et al.  Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.

[29]  J. Power,et al.  Severe congestive heart failure and cardiomyopathy as a complication of myotonic dystrophy in pregnancy , 1990, Obstetrics and gynecology.

[30]  M. Aminoff,et al.  Autonomic function in myotonic dystrophy. , 1985, Archives of neurology.

[31]  R. Newcombe,et al.  Blood pressure and myotonic dystrophy , 1983, Clinical genetics.

[32]  F. Nuttall,et al.  Thin Muscle Capillary Basement Membranes in Myotonic Dystrophy , 1979, Diabetes.

[33]  P. Freedson,et al.  Scientific Statement From the American Heart Association Guide to the Assessment of Physical Activity: Clinical and Research Applications: A , 2015 .